<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">46043</article-id><article-id pub-id-type="doi">10.7554/eLife.46043</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Immunology and Inflammation</subject></subj-group></article-categories><title-group><article-title>Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-131724"><name><surname>Brian</surname><given-names>Ben F</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141975"><name><surname>Jolicoeur</surname><given-names>Adrienne S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-143962"><name><surname>Guerrero</surname><given-names>Candace R</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-131725"><name><surname>Nunez</surname><given-names>Myra G</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141977"><name><surname>Sychev</surname><given-names>Zoi E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145208"><name><surname>Hegre</surname><given-names>Siv A</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145209"><name><surname>Sætrom</surname><given-names>Pål</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-145210"><name><surname>Habib</surname><given-names>Nagy</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-141976"><name><surname>Drake</surname><given-names>Justin M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-131726"><name><surname>Schwertfeger</surname><given-names>Kathryn L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-35371"><name><surname>Freedman</surname><given-names>Tanya S</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5168-5829</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Pharmacology</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">College of Biological Sciences Center for Mass Spectrometry and Proteomics</institution>, <institution>University of Minnesota</institution>, <addr-line><named-content content-type="city">Minneapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Clinical and Molecular Medicine</institution>, <institution>Norwegian University of Science and Technology</institution>, <addr-line><named-content content-type="city">Trondheim</named-content></addr-line>, <country>Norway</country></aff><aff id="aff4"><institution content-type="dept">Department of Surgery and Cancer</institution>, <institution>Imperial College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1072"><name><surname>Davis</surname><given-names>Roger J</given-names></name><role>Reviewing editor</role><aff><institution>University of Massachusetts Medical School</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>tfreedma@umn.edu</email> (TF);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>08</day><month>07</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e46043</elocation-id><history><date date-type="received"><day>14</day><month>02</month><year>2019</year></date><date date-type="accepted"><day>06</day><month>07</month><year>2019</year></date></history><permissions><copyright-statement>© 2019, Brian et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Brian et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-46043-v1.pdf"/><abstract><p>The activity of Src-family kinases (SFKs), which phosphorylate immunoreceptor tyrosine-based activation motifs (ITAMs), is a critical factor regulating myeloid-cell activation. We reported previously that the SFK LynA is uniquely susceptible to rapid ubiquitin-mediated degradation in macrophages, functioning as a rheostat regulating signaling (Freedman <italic>et al.</italic>, 2015). We now report the mechanism by which LynA is preferentially targeted for degradation and how cell specificity is built into the LynA rheostat. Using genetic, biochemical, and quantitative phosphopeptide analyses, we found that the E3 ubiquitin ligase c-Cbl preferentially targets LynA via a phosphorylated tyrosine (Y32) in its unique region. This distinct mode of c-Cbl recognition depresses steady-state expression of LynA in macrophages derived from mice. Mast cells, however, express little c-Cbl and have correspondingly high LynA. Upon activation, mast-cell LynA is not rapidly degraded, and SFK-mediated signaling is amplified relative to macrophages. Cell-specific c-Cbl expression thus builds cell specificity into the LynA checkpoint.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01AR073966</award-id><principal-award-recipient><name><surname>Freedman</surname><given-names>Tanya S</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R03AI130978</award-id><principal-award-recipient><name><surname>Freedman</surname><given-names>Tanya S</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>UMN IRG-58-001-55</award-id><principal-award-recipient><name><surname>Freedman</surname><given-names>Tanya S</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007249</institution-id><institution>University of Minnesota</institution></institution-wrap></funding-source><award-id>Grant-in-Aid #92286</award-id><principal-award-recipient><name><surname>Freedman</surname><given-names>Tanya S</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007249</institution-id><institution>University of Minnesota</institution></institution-wrap></funding-source><award-id>Research and Equipment Award NF-0315-02</award-id><principal-award-recipient><name><surname>Freedman</surname><given-names>Tanya S</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100007249</institution-id><institution>University of Minnesota</institution></institution-wrap></funding-source><award-id>Center for Autoimmune Diseases Research Pilot Grant</award-id><principal-award-recipient><name><surname>Freedman</surname><given-names>Tanya S</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>R01CA215052</award-id><principal-award-recipient><name><surname>Schwertfeger</surname><given-names>Kathryn L</given-names></name></principal-award-recipient></award-group><award-group id="par-8"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000052</institution-id><institution>NIH Office of the Director</institution></institution-wrap></funding-source><award-id>T32DA007097</award-id><principal-award-recipient><name><surname>Brian</surname><given-names>Ben F</given-names></name></principal-award-recipient></award-group><award-group id="par-9"><funding-source><institution-wrap><institution>Research Council of Norway</institution></institution-wrap></funding-source><award-id>230338</award-id><principal-award-recipient><name><surname>Sætrom</surname><given-names>Pål</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal use complies with University of Minnesota (UMN) and National Institutes of Health (NIH) policy (Animal Welfare Assurance Number A3456-01). UMN is accredited by AAALAC, and all animal use was approved by the UMN Institutional Animal Care and Use Committee (IACUC, protocol # 1603-33559A). Animals are kept under supervision of a licensed doctor of veterinary medicine and supporting veterinary staff under strict NIH guidelines.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.  Source data files have been provided for graphs in Figure 1, Figure 1-figure supplement 1, Figure 2, Figure 3, Figure 3-figure supplement 2, Figure 4, Figure 4-figure supplement 1, Figure 4-figure supplement 5, Figure 5, Figure 6, Figure 6-figure supplement 1, Figure 7, Figure 8, and Figure 9.Data sets and calibration curves resulting from our targeted mass spectrometry studies have been deposited in Panorama Public (https://panoramaweb.org/project/Panorama%20Public/begin.view?)</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Freedman T</collab></person-group><year iso-8601-date="2019">2019</year><source>Unique-region phosphorylation targets LynA for rapid degradation, tuning its expression and signaling in myeloid cells</source><ext-link ext-link-type="uri" xlink:href="http://panoramaweb.org/Freedman_LynA.url">http://panoramaweb.org/Freedman_LynA.url</ext-link><comment>Panorama</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Heng TS</collab><collab>Painter MW</collab></person-group><year iso-8601-date="2008">2008</year><source>Immunological Genome Project C. The Immunological Genome Project: networks of gene expression in immune cells</source><ext-link ext-link-type="uri" xlink:href="http://rstats.immgen.org/Skyline/skyline.html">http://rstats.immgen.org/Skyline/skyline.html</ext-link><comment>ImmGen RNA-Seq</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Dwyer DF</collab><collab>Barrett NA</collab><collab>Austen KF</collab></person-group><year iso-8601-date="2016">2016</year><source>Immunological Genome Project C. Expression profiling of constitutive mast cells reveals a unique identity within the immune system</source><ext-link ext-link-type="uri" xlink:href="http://rstats.immgen.org/Skyline/skyline.html">http://rstats.immgen.org/Skyline/skyline.html</ext-link><comment>ImmGen RNA-Seq</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-46043-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>